Bioproperties' Vaxsafe ILT vaccine is used to prevent infectious laryngotracheitis (ILT), a highly contagious respiratory disease in chickens caused by the Gallid herpesvirus 1. Uses a genetically modified (attenuated) strain of the virus that is weakened so it does not cause disease.
Infectious Laryngotracheitis vaccine is indicated for prevention of infectious laryngotracheitis (ILT) disease in chickens.
INDICATIONS
To protect chickens against clinical signs and tracheal pathology caused by virulent field strains of ILT virus.
As an aid in limiting the spread of an ILT outbreak in a region, though only uninfected birds can be protected in such cases.
In commercial poultry operations where there is a history or a persistent risk of ILT infection.
The vaccine is typically administered via eye-drop to chickens when they are a few weeks of age (e.g., 4 weeks or as early as 10 days, depending on specific program requirements).
FEATURES
Prevents respiratory disease: The primary purpose is to protect chickens from ILT, which can cause symptoms like gasping, bloody discharge, and decreased productivity.
Uses an attenuated virus: Contains a modified strain of the ILT virus that is less harmful, but stimulates an immune response.
ADMINISTRATION
Eye Drop: A full drop is given into the open eye, ensuring proper absorption.
Drinking Water: Birds are deprived of water for a short period, then given medicated water containing the vaccine (often with skim milk powder as a stabilizer).
Spray: Can be used for mass vaccination, delivering the vaccine via fine mist.
Subcutaneous Injection: A 0.2 mL dose is injected under the skin, usually in the neck, for individual birds, often at one day old.
In Ovo: Administered directly into the egg during incubation.